Johnson & Johnson (JNJ)
Quick ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 18,231,000 | 18,577,000 | 38,474,000 | 24,105,000 | 19,980,000 | 24,878,000 | 25,473,000 | 21,859,000 | 19,728,000 | 21,183,000 | 19,170,000 | 12,889,000 | 11,355,000 | 10,983,000 | 10,463,000 | 14,487,000 | 17,604,000 | 14,332,000 | 12,671,000 | 13,985,000 |
| Short-term investments | US$ in thousands | 331,000 | 303,000 | 307,000 | 417,000 | 317,000 | 597,000 | 745,000 | 1,068,000 | 3,783,000 | 7,322,000 | 5,443,000 | 9,392,000 | 22,724,000 | 21,585,000 | 19,925,000 | 17,121,000 | 13,397,000 | 10,974,000 | 11,948,000 | 11,200,000 |
| Receivables | US$ in thousands | 17,611,000 | 17,846,000 | 16,020,000 | 18,927,000 | 16,174,000 | 15,794,000 | 14,946,000 | 19,387,000 | 14,798,000 | 16,777,000 | 16,350,000 | 16,915,000 | 15,890,000 | 16,139,000 | 15,594,000 | 18,984,000 | 14,911,000 | 14,871,000 | 14,938,000 | 13,576,000 |
| Total current liabilities | US$ in thousands | 50,869,000 | 54,180,000 | 56,903,000 | 50,321,000 | 51,759,000 | 53,933,000 | 48,725,000 | 46,282,000 | 44,370,000 | 54,170,000 | 60,373,000 | 55,802,000 | 45,543,000 | 44,821,000 | 43,390,000 | 45,226,000 | 44,561,000 | 38,721,000 | 40,932,000 | 42,493,000 |
| Quick ratio | 0.71 | 0.68 | 0.96 | 0.86 | 0.70 | 0.77 | 0.84 | 0.91 | 0.86 | 0.84 | 0.68 | 0.70 | 1.10 | 1.09 | 1.06 | 1.12 | 1.03 | 1.04 | 0.97 | 0.91 |
September 30, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($18,231,000K
+ $331,000K
+ $17,611,000K)
÷ $50,869,000K
= 0.71